Business Context and Reporting Period
This Form 8-K Current Report was filed by Bausch + Lomb Corporation on September 14, 2023. The filing details a significant capital raising event involving the pricing of senior secured notes and the arrangement of an incremental term loan facility.
Key Financial Metrics and Capital Structure
- Secured Notes Offering: Priced $1.4 billion aggregate principal amount of 8.375% senior secured notes due 2028.
- Term Loan Facility: Arranged an incremental term loan facility to borrow $500 million in new Term B loans.
- Issuance Price: Notes sold at 100% of principal amount.
- Use of Proceeds: Funds are designated for the pending acquisition of XIIDRA and certain other ophthalmology assets, transaction fees, repayment of existing debt, and general corporate purposes.
Material Changes and Transaction Mechanics
The filing outlines a complex financing structure contingent on the closing of the XIIDRA acquisition:
- Escrow Mechanism: If the notes are issued prior to the acquisition closing, proceeds will be held in a segregated escrow account. Upon acquisition closing, the Company will assume the obligations and release the funds.
- Redemption Condition: If the acquisition does not occur by September 30, 2024, the Escrow Issuer must redeem the notes at par plus accrued interest.
- Closing Dates: The notes offering is expected to close on September 29, 2023, independent of the acquisition completion. The term loan facility closing is conditioned upon and concurrent with the acquisition closing.
Guidance, Risks, and Contingencies
The filing does not provide updated financial guidance, revenue forecasts, or management commentary on operational performance. Key contingencies include:
- Acquisition Dependency: The release of escrowed funds and the closing of the term loan facility are contingent on the successful completion of the XIIDRA acquisition.
- Regulatory Status: The notes are offered under Rule 144A and Regulation S exemptions and are not registered for public sale in the U.S. or Canada.
Investor Verification Checklist
- Verify the final closing date of the XIIDRA acquisition to confirm the release of escrowed funds.
- Monitor the September 29, 2023, closing date for the $1.4 billion notes offering.
- Review the definitive indenture for the 8.375% senior secured notes due 2028.
- Assess the impact of the new $1.9 billion in total debt ($1.4B notes + $500M term loan) on the company's leverage ratios.